Stock Information
PTC Therapeutics Inc (PTCT)
Ticker Symbol: PTCT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,158.84 mil
Piotroski score: 4
PE Ratio: 7.4177
EPS (TTM): 8.5309
Revenue (TTM): $20.42 M
Dividend Yield: N/A%
ROE: -351.91%
Latest News
-
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
Fri, Feb 13, 2026 7:18 AM
-
PTC Therapeutics Withdraws Its New Drug Application Resubmission For Translarna For Duchenne Muscular Dystrophy Treatment After FDA Feedback
Thu, Feb 12, 2026 6:02 PM
-
PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup
Thu, Feb 12, 2026 12:11 PM
Key Financials
Financial data not available
